Endotracheal N-acetylcysteine for Atelectasis in Neonatal Pneumonia

  • Dilek M
  • Atasoy H
  • Açar S
N/ACitations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Although there is no gold standard therapy in the treatment of atelectasis in newborns, surfactant therapy, inhaled mucolytic agents, recombinant human deoxyribonuclease, positive pressure mechanical ventilation, postural changes and drainage can be used. However, N-acetylcysteine (NAC), via endo-bronchoscopy, is rarely used to break the disulfide bonds in the mucus. It is a cheap and readily available treatment to apply. Here, we present a newborn with neonatal pneumonia to whom we instilled NAC thorough an endotracheal tube to resolve right lung total atelectasis. The atelectasis responded to instillation quickly and successfully. We are presenting this case in order to suggest a novel effective treatment modality for already intubated newborns with atelectasis. This case also represents the first successful treatment case in the newborn period. [ABSTRACT FROM AUTHOR]

Cite

CITATION STYLE

APA

Dilek, M., Atasoy, H. İ., & Açar, S. (2019). Endotracheal N-acetylcysteine for Atelectasis in Neonatal Pneumonia. The Journal of Pediatric Research, 6(4), 359–362. https://doi.org/10.4274/jpr.galenos.2019.57442

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free